LLC0424 is a potent and selective degrader of the nuclear receptor-binding SET domain 2 (NSD2), with a DC50 of 20 nM. It reduces H3K36me2 levels and inhibits the growth of acute lymphoblastic leukemia (ALL) cell lines, making it useful for research in ALL.
Target:
PROTACs|||Histone Methyltransferase
* VAT and and shipping costs not included. Errors and price changes excepted
